BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27193293)

  • 1. Quantification of the HIV transcriptional activator complex in live cells by image-based protein-protein interaction analysis.
    Asamitsu K; Omagari K; Okuda T; Hibi Y; Okamoto T
    Genes Cells; 2016 Jul; 21(7):706-16. PubMed ID: 27193293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.
    Mbonye UR; Gokulrangan G; Datt M; Dobrowolski C; Cooper M; Chance MR; Karn J
    PLoS Pathog; 2013; 9(5):e1003338. PubMed ID: 23658523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing the formation of positive transcription elongation factor b by human cyclin T1-binding RNA aptamer for anti-HIV transcription.
    Um HJ; Kim M; Lee SH; Kim YH
    AIDS; 2012 Aug; 26(13):1599-605. PubMed ID: 22569018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.
    O'Brien SK; Cao H; Nathans R; Ali A; Rana TM
    J Biol Chem; 2010 Sep; 285(39):29713-20. PubMed ID: 20551309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
    Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
    Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4.
    Gu J; Babayeva ND; Suwa Y; Baranovskiy AG; Price DH; Tahirov TH
    Cell Cycle; 2014; 13(11):1788-97. PubMed ID: 24727379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat.
    Schulze-Gahmen U; Upton H; Birnberg A; Bao K; Chou S; Krogan NJ; Zhou Q; Alber T
    Elife; 2013 Mar; 2():e00327. PubMed ID: 23471103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.
    Imai K; Asamitsu K; Victoriano AF; Cueno ME; Fujinaga K; Okamoto T
    FEBS J; 2009 Dec; 276(23):7124-33. PubMed ID: 20064163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant negative mutant cyclin T1 proteins that inhibit HIV transcription by forming a kinase inactive complex with Tat.
    Jadlowsky JK; Nojima M; Okamoto T; Fujinaga K
    J Gen Virol; 2008 Nov; 89(Pt 11):2783-2787. PubMed ID: 18931076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1.
    Kuzmina A; Hadad U; Fujinaga K; Taube R
    Virology; 2012 May; 426(2):152-61. PubMed ID: 22342181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.
    Ivanov A; Lin X; Ammosova T; Ilatovskiy AV; Kumari N; Lassiter H; Afangbedji N; Niu X; Petukhov MG; Nekhai S
    Retrovirology; 2018 May; 15(1):39. PubMed ID: 29792216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of HIV-1 Tat complexed with human P-TEFb.
    Tahirov TH; Babayeva ND; Varzavand K; Cooper JJ; Sedore SC; Price DH
    Nature; 2010 Jun; 465(7299):747-51. PubMed ID: 20535204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.
    Wang Q; Young TM; Mathews MB; Pe'ery T
    J Mol Biol; 2007 Mar; 367(3):630-46. PubMed ID: 17289077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.
    Kuzmina A; Krasnopolsky S; Taube R
    Transcription; 2017 May; 8(3):133-149. PubMed ID: 28340332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
    Rice AP
    Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
    Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
    mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages.
    Rice AP; Herrmann CH
    Curr HIV Res; 2003 Oct; 1(4):395-404. PubMed ID: 15049426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.